We are live on ! Find out more
PDEX icon

Pro-Dex

72.55 USD
+3.07
4.42%
At close Updated Sep 18, 4:00 PM EDT
Pre-market
After hours
72.50
-0.05
0.07%
1 day
4.42%
5 days
15.53%
1 month
8.46%
3 months
12.71%
6 months
48.15%
Year to date
92.34%
1 year
108.72%
5 years
178.29%
10 years
1,389.73%
 

About: Pro-Dex Inc is engaged in the design, development, manufacture, sale and repair of handheld medical devices and accessories, with products including Powered Surgical Drivers, Precision Air Powered Motors and others, including autoclavable, battery-powered and electric multi-function surgical drivers and shavers used mainly in the orthopedic, thoracic and craniomaxillofacial markets, as well as providing engineering, quality, regulatory consulting, NRE and prototype services, and manufacturing and selling rotary air motors and precision machined parts and assemblies for the aerospace and defense industries, with the majority of revenue derived from designing, developing, manufacturing and repairing powered surgical instruments for medical device original equipment manufacturers.

Employees: 206

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 66.7%
Neutral 33.3%
Negative 0%
Positive
Zacks Investment Research
16 hours ago
Best Momentum Stocks to Buy for September 18th
PDEX, APH and RELY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 18th, 2026.
Best Momentum Stocks to Buy for September 18th
Positive
Zacks Investment Research
21 hours ago
New Strong Buy Stocks for September 18th
PGY, OPHC, PDEX, TRV and HMN have been added to the Zacks Rank #1 (Strong Buy) List on September 18th, 2026.
New Strong Buy Stocks for September 18th
Neutral
Accesswire
15 days ago
Pro-Dex, Inc. Announces Fiscal 2026 Fourth Quarter and Full-Year Results
IRVINE, CA / ACCESS Newswire / September 3, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 fourth quarter and full-year ended June 30, 2026.
Pro-Dex, Inc. Announces Fiscal 2026 Fourth Quarter and Full-Year Results
Neutral
Seeking Alpha
4 months ago
Pro-Dex: Still A Buy, But Don't Chase
Pro-Dex reported nice Q1 sales of $19.9 million, which is up 14.6% YoY. Their largest customer contract now runs through December 2028, reducing potential near-term risks in that sense. Also, their APM acquisition gives them more control over their supply chain and brings some potential aerospace/defense optionality.
Pro-Dex: Still A Buy, But Don't Chase
Neutral
Accesswire
4 months ago
Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results
IRVINE, CA / ACCESS Newswire / April 30, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 third quarter ended March 31, 2026.
Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results
Neutral
Accesswire
7 months ago
Pro-Dex, Inc. Announces Acquisition of Advanced Precision Machining
IRVINE, CA / ACCESS Newswire / February 12, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced that on February 9, 2026 it completed its acquisition of Advanced Precision Machining LLC, ("APM"), formerly operated as Advanced Precision Machining, Inc., a manufacturing facility located in Costa Mesa, Calif.
Pro-Dex, Inc. Announces Acquisition of Advanced Precision Machining
Neutral
Accesswire
7 months ago
Pro-Dex, Inc. Announces Fiscal 2026 Second Quarter and Six-Month Results
IRVINE, CA / ACCESS Newswire / January 29, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 second quarter ended December 31, 2025.
Pro-Dex, Inc. Announces Fiscal 2026 Second Quarter and Six-Month Results
Positive
Seeking Alpha
8 months ago
Pro-Dex: A Niche Surgical Tools Microcap Trading At A Discount
Pro-Dex manufactures powered surgical instruments for orthopedic, CMF, and thoracic procedures. This means that PDEX effectively combines OEM programs with a smaller catalog of industrial offerings. However, PDEX's revenue today remains highly concentrated. A single customer drives roughly 78% of sales.
Pro-Dex: A Niche Surgical Tools Microcap Trading At A Discount
Positive
Seeking Alpha
8 months ago
Pro-Dex Valuation Is Attractive Despite Customer Risk
Pro-Dex Inc. is a specialized surgical device manufacturer with strong growth, efficient capital allocation, and high customer concentration risk. PDEX trades at ~16x recurrent earnings, which is fair and attractive for a small, non-concentrated position given its quality and growth prospects. Customer concentration remains the key risk, but contract renewals, sticky relationships, and secular healthcare tailwinds support continued growth.
Pro-Dex Valuation Is Attractive Despite Customer Risk
Neutral
Accesswire
9 months ago
Pro-Dex, Inc. Announces Contract Extension With Largest Customer
IRVINE, CA / ACCESS Newswire / December 19, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced that on December 17, 2025, it executed a contract amendment with its largest customer for an additional three years.
Pro-Dex, Inc. Announces Contract Extension With Largest Customer
Price charts implemented using Lightweight Charts™